Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Cytokine & Growth Factor Reviews|September 7, 2020
Tumour vasculature: Friend or foe of oncolytic viruses?Lisa A Santry, Jacob P van Vloten, Jason P Knapp, et al.
Human Gene Therapy|February 1, 2020
Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene DeliveryMaría C Rosales Gerpe, Laura P van Lieshout, Jakob M Domm, et al.
Gene Therapy|February 2, 2023
Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxisAmira D Rghei, Jacob G E Yates, Jordyn A Lopes, et al.
Molecular Therapy Oncolytics|December 11, 2023
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancerJessica A Minott, Jacob P van Vloten, Jake G E Yates, et al.
Molecular Therapy Oncolytics|February 22, 2021
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer modelsThomas M McAusland, Jacob P van Vloten, Lisa A Santry, et al.
Oncolytic Virotherapy|December 13, 2018
Development and applications of oncolytic Maraba virus vaccinesJonathan G Pol, Matthew J Atherton, Byram W Bridle, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challengeLaura P van Lieshout, Amira D Rghei, Wenguang Cao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2012
ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeuticJulia L Rintoul, Chantal G Lemay, Lee-Hwa Tai, et al.
Pageof 9